Second, glioblastoma patients with IDH1 mutation and MGMT promotor methylation are significantly associated with long-term survival (Stupp et al. 2009; Iuchi et al. 2014; Molenaar et al. 2014; Shenouda et al. 2017). Here, IDH1 is linked to glioblastoma.